Alimera Sciences (NASDAQ:ALIM) just reported results for the second quarter of 2024.
- Alimera Sciences reported earnings per share of -6 cents. This was below the analyst estimate for EPS of -4 cents.
- The company reported revenue of $27.00 million.
- This was 4.94% better than the analyst estimate for revenue of $25.73 million.